Krystal Biotech, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Krystal Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2016 to Q2 2024.
  • Krystal Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $15.6M.
  • Krystal Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $106M.
  • Krystal Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $10.9M.
  • Krystal Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$140M, a 101% decline from 2021.
  • Krystal Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$69.6M, a 116% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $106M $15.6M +$48.8M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $57.2M $932K +$46.2M Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-05
Q4 2023 $10.9M $8.69M +$40.7M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 -$29.8M $80.7M +$111M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$140M -$33.2M -$5.1M -18.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$135M -$45.3M +$4.67M +9.34% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-05
Q4 2022 -$140M -$32.1M -$10.2M -47% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 -$130M -$29.9M -$14.3M -91.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$115M -$28.1M -$11.7M -71.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 -$104M -$50M -$34.2M -216% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2021 -$69.6M -$21.8M -$11.4M -110% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$58.1M -$15.6M -$5.98M -62.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$52.2M -$16.4M -$9.53M -139% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$42.6M -$15.8M -$10.5M -196% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 -$32.2M -$10.4M -$5.03M -93.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$27.1M -$9.61M -$5.34M -125% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$21.8M -$6.83M -$1.49M -27.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$20.3M -$5.34M -$1.23M -29.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 -$19.1M -$5.36M -$1.65M -44.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$17.4M -$4.27M -$1.52M -55.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$15.9M -$5.35M -$3.07M -135% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$12.9M -$4.11M -$1.96M -91.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$10.9M -$3.71M -$2.31M -166% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$8.58M -$2.76M +$2.52M +47.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 -$11.1M -$2.28M -$1.52M -200% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-04
Q1 2018 -$9.58M -$2.15M -$1.66M -335% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-04
Q4 2017 -$7.92M -$1.39M Oct 1, 2017 Dec 31, 2017 10-K 2018-03-12
Q3 2017 -$5.27M -$4.95M -1538% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$759K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$494K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q3 2016 -$322K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.